EUVIMEDEUVIMED entdecken
Kohortenstudie

Differential Effects of Metformin on Immune-Mediated and Androgen-Mediated Non-Cancer Skin Diseases in Diabetes Patients: A Retrospective Cohort Study

Chin-Hsiao Tseng

Dermatology · 2023

DOI: 10.1159/000530077 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Dermatology, 2023. Verfasst von Chin-Hsiao Tseng. Beteiligte Einrichtung: Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. Hauptthemen laut MEDLINE: Metformin, Diabetes Mellitus, Type 2, Hidradenitis Suppurativa, Acne Vulgaris. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metformin’s effects on non-cancer skin diseases are rarely investigated.

Objective

The aim of the study was to investigate immune-mediated (urticaria, allergic contact dermatitis, and psoriasis) and androgen-mediated (acanthosis nigricans, hidradenitis suppurativa, and acne) skin diseases associated with metformin use.

Methods

Metformin initiators (n = 234,585) and non-metformin initiators (n = 125,921) within the initial 12 months of antidiabetic drug prescription during 1999–2009 were followed up until December 31, 2011. Cox regression weighted for propensity score was used to estimate hazard ratios for metformin initiators versus non-metformin initiators in intention-to-treat (ITT) and per-protocol (PP) analyses.

Results

For immune-mediated skin diseases, hazard ratios were 0.930 (95% confidence interval: 0.920–0.940) and 0.930 (0.918–0.943) in ITT and PP analyses, respectively, and the hazard ratios for each specific outcome were all significantly below unity. For androgen-mediated skin diseases, the ITT and PP hazard ratios were 1.110 (1.060–1.162) and 0.990 (0.935–1.048), respectively, and all hazard ratios were not significant for each specific outcome except for acne in the ITT analysis (hazard ratio: 1.116, 95% confidence interval: 1.064–1.170).

Conclusion

Metformin use is associated with a significantly lower risk of immune-mediated skin diseases but lacks a preventive effect on androgen-mediated skin diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminDiabetes Mellitus, Type 2Hidradenitis SuppurativaAcne VulgarisHumansAndrogensRetrospective Studies

Stichwörter der Autor:innen

Acanthosis nigricansAcneAllergic contact dermatitisHidradenitis suppurativaMetforminPsoriasisUrticaria

Substanzen

MetforminAndrogens

Autor:innen und Institutionen

  • Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • National Institute of Environmental Health Sciences of the National Health Research Institutes, Zhunan, Taiwan.

Zitieren

APA

Tseng, C. H. (2023). Differential Effects of Metformin on Immune-Mediated and Androgen-Mediated Non-Cancer Skin Diseases in Diabetes Patients: A Retrospective Cohort Study. Dermatology. https://doi.org/10.1159/000530077

Vancouver

Tseng CH. Differential Effects of Metformin on Immune-Mediated and Androgen-Mediated Non-Cancer Skin Diseases in Diabetes Patients: A Retrospective Cohort Study. Dermatology. 2023. doi:10.1159/000530077

BibTeX
@article{Tseng2023,
  author = {Tseng, Chin-Hsiao},
  title = {Differential Effects of Metformin on Immune-Mediated and Androgen-Mediated Non-Cancer Skin Diseases in Diabetes Patients: A Retrospective Cohort Study},
  journal = {Dermatology},
  year = {2023},
  doi = {10.1159/000530077}
}
Kostenlos starten →